Amgen Inc. Uncategorized Contracts & Agreements

128 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Agreement between Amgen Inc. and James Bradner, dated December 13, 2023
Amgen Inc.
Biotechnology
2024
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2024
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2023
Appendix 3 to the Rule 2.7 Announcement, dated as of December 12, 2022 (Conditions Appendix)
Amgen Inc.
Biotechnology
2022
Transaction Agreement, dated as of December 11, 2022, by and among Amgen Inc., Pillartree Limited and Horizon Therapeutics plc
Amgen Inc.
Biotechnology
DE
2022
Form of ASR Agreement
Amgen Inc.
Biotechnology
NY
2022
Aircraft Time Sharing Agreement, dated December 3, 2021, by and between Amgen Inc. and Robert A. Bradway
Amgen Inc.
Biotechnology
NY
2022
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2022
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2021
Agreement between Amgen Inc. and Peter Griffith, dated October 18, 2019
Amgen Inc.
Biotechnology
2020
Letter Agreement, dated November 21, 2019, by and between Amgen Inc. and the parties named therein re: Treatment of Certain Product Inventory in connection with Amgens acquisition...
Amgen Inc.
Biotechnology
2020
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2020
Letter Agreement, dated June 25, 2019, by and between Amgen Inc. and UCB Celltech (portions of the exhibit have been omitted because they are both (i) not material and (ii) would...
Amgen Inc.
Biotechnology
2019
Agreement between Amgen Inc. and Murdo Gordon, dated July 25, 2018
Amgen Inc.
Biotechnology
2018
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2017
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2017
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2017
Form of Award Notice
Amgen Inc.
Biotechnology
2017
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2016
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2016
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2016
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2016
Form of Award Notice
Amgen Inc.
Biotechnology
2016
TERMS AND CONDITIONS
Amgen Inc.
Biotechnology
NY
2016
Form of Permanent Global Certificate (Globalurkunde auf Dauer) of CHF 700,000,000 (700,000,000 Swiss francs) Amgen Inc. One AmgenCenter Drive Thousand Oaks, California...
Amgen Inc.
Biotechnology
CA
2016
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2016
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2014
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2014
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2014
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED BANK OF AMERICA, N.A. One Bryant Park New York, New York 10036
Amgen Inc.
Biotechnology
NY
2013
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2013